| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Nov―03 |
Targeted structural design of molecular scaffolds for dual-action peptidomimetic inhibitors against SARS-CoV-2 MPRO and PLPRO |
Larysa Yevsieieva, Alexander Kyrychenko, Pavlo Trostianko, Volodymyr Ivanov, Sergiy M. Kovalenko, Oleg Kalugin |
| 2 |
[GO] |
2025―Jul―02 |
A comparative retrospective study on the efficacy of Azvudine and Lianhua Qingwen capsules combination in the treatment of COVID-19 patients in China |
Jingjing Gu, Simansalam Saraswathi, Thamby Sam, Xiufeng Liu |
| 3 |
[GO] |
2024―Dec―31 |
Design of non-covalent dual-acting inhibitors for proteases MPRO and PLPRO of coronavirus SARS-CoV-2 through evolutionary library generation, pharmacophore profile matching, and molecular docking calculations |
Larysa Yevsieieva, Pavlo Trostianko, Alexander Kyrychenko, Volodymyr Ivanov, Sergiy Kovalenko, Oleg Kalugin |
| 4 |
[GO] |
2024―Jan―26 |
Recent advances in computational drug discovery for therapy against coronavirus SARS-CoV-2 |
Volodymyr Ivanov, Kateryna Lohachova, Yaroslav Kolesnik, Anton Zakharov, Larysa Yevsieieva, Alexander Kyrychenko, Thierry Langer, Sergiy M. Kovalenko, Oleg N. Kalugin |
|
